文献速递胸部肿瘤

软脑膜与实体肺癌脑转移的复发突变基因差异

Recurrently Mutated Genes Differ between Leptomeningeal and Solid Lung Cancer Brain Metastases.
PubMed 文献 · J Thorac Oncol · 2018-03-29

研究对8例非小细胞肺癌软脑膜病变(LMD)样本行全外显子测序,并与26例实体脑转移比较,发现TAS2R31和PDE4DIP在LMD中反复突变。结合额外44例LMD病历回顾,KRAS突变仅4例(7.7%),EGFR突变33例(63.5%);EGFR突变者LMD发生中位间隔16.3个月,短于野生型的23.9个月(p=0.017)。

要点

  • LMD中TAS2R31和PDE4DIP反复突变,提示参与LMD进展。
  • LMD患者KRAS突变率低(7.7%),EGFR突变率高(63.5%)。
  • EGFR突变者LMD发生间隔更短(16.3 vs 23.9个月,p=0.017)。

核心结论

  • LMD与实体脑转移存在分子差异,TAS2R31和PDE4DIP反复突变可能参与LMD进展。
  • LMD中KRAS突变少见而EGFR突变常见,EGFR突变者LMD发生间隔更短。

研究设计与样本

  • 对8例LMD样本行全外显子测序识别体细胞突变,并与26例实体脑转移比较。
  • 回顾性查阅额外44例NSCLC LMD患者病历。

主要发现

  • TAS2R31和PDE4DIP在LMD样本中反复突变。
  • LMD患者KRAS突变4例(7.7%),EGFR突变33例(63.5%)。
  • EGFR突变者LMD发生中位间隔16.3个月,野生型23.9个月(p=0.017)。

临床怎么用

  • 复发突变靶向分析可作为现有诊断工具的有用补充。
  • LMD与实体转移的EGFR/KRAS差异提示分子区分或系统治疗压力影响脑内生长模式。

局限性

  • LMD样本量小(8例全外显子测序)。
  • LMD患者不行手术切除,组织获取受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

When compared with solid brain metastases from NSCLC, leptomeningeal disease (LMD) has unique growth patterns and is rapidly fatal. Patients with LMD do not undergo surgical resection, limiting the tissue available for scientific research. In this study we performed whole exome sequencing on eight samples of LMD to identify somatic mutations and compared the results with those for 26 solid brain metastases. We found that taste 2 receptor member 31 gene (TAS2R31) and phosphodiesterase 4D interacting protein gene (PDE4DIP) were recurrently mutated among LMD samples, suggesting involvement in LMD progression. Together with a retrospective review of the charts of an additional 44 patients with NSCLC LMD, we discovered a surprisingly low number of KRAS mutations (n = 4 [7.7%]) but a high number of EGFR mutations (n = 33 [63.5%]). The median interval for development of LMD from NSCLC was shorter in patients with mutant EGFR (16.3 months) than in patients with wild-type EGFR (23.9 months) (p = 0.017). Targeted analysis of recurrent mutations thus presents a useful complement to the existing diagnostic tool kit, and correlations of EGFR in LMD and KRAS in solid metastases suggest that molecular distinctions or systemic treatment pressure underpin the differences in growth patterns within the brain.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Li Y, Liu B, Connolly ID, et al. Recurrently Mutated Genes Differ between Leptomeningeal and Solid Lung Cancer Brain Metastases. J Thorac Oncol. 2018. PMID: 29604399. doi:10.1016/j.jtho.2018.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。